Skip to main content
FinSpry Logo
FinSpry
GERN logo
GERN
(NASDAQ)
Geron Corporation
$1.52-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Geron (GERN) Stock Price & Financial Analysis

Geron Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.45 - $1.55
52-Week High$2.01
52-Week Low$1.04
Open$1.46
Volume8.41M
Average Volume (3M)10.47M
Market Cap1.02B
Shares Outstanding669.38M
Price to Sales (P/S)5.22
Price to Book (P/B)4.47
EV/EBITDA-31.24
Revenue (TTM)196.12M
Net Income (TTM)-67.31M
Free Cash Flow (TTM)-126.33M
EPS (TTM)$-0.10
Profit Margin-34.32%
Operating Margin-17.89%
Return on Equity (ROE)-29.38%
Debt to Equity1.10
50-Day MA$1.38
200-Day MA$1.41
52-Week Change5.52%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Geron

What is the current stock price for GERN?

As of the latest trading session, GERN stock trades at $1.53. The 52-week range is $1.04–$2.01, with a day range of $1.45–$1.55.

What is the P/E ratio for GERN?

The P/E ratio (Price-to-Earnings) for GERN is shown in the Key Statistics section. This valuation metric helps compare Geron Corporation to industry peers.

Does GERN pay dividends?

Geron does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for GERN?

Analyst ratings and recommendations for GERN are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of GERN?

Geron's market capitalization is $1.02B, classifying it as a small-cap company. Geron operates in the Healthcare sector within the Biotechnology industry.